Showing results (31-40 of 188) with videos related to

Sort By:
Pageof 19
Journal of the European Academy of Dermatology and Venereology : JEADV|September 18, 2014
An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factorsP P M van Lümig, S P Menting, J M P A van den Reek, et al.
Annals of the Rheumatic Diseases|May 21, 2008
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rateG Wells, J-C Becker, J Teng, et al.
Annals of the Rheumatic Diseases|November 3, 2007
Psychometric properties of the Rheumatoid Arthritis Disease Activity Index (RADAI) in a cohort of consecutive Dutch patients with RA starting anti-tumour necrosis factor treatmentM M Veehof, P M ten Klooster, E Taal, et al.
Annals of the Rheumatic Diseases|November 26, 2005
Methotrexate modulates the kinetics of adenosine in humans in vivoN P Riksen, P Barrera, P H H van den Broek, et al.
Annals of the Rheumatic Diseases|April 4, 2008
The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritisE J M Toonen, M J H Coenen, W Kievit, et al.
Annals of the Rheumatic Diseases|February 9, 2006
Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE studyP L C M van Riel, A J Taggart, J Sany, et al.
Arthritis and Rheumatism|October 3, 2006
Comment on the use of self-reporting instruments to assess patients with rheumatoid arthritis: the longitudinal association between the DAS28 and the VAS general healthW Kievit, P M J Welsing, E M M Adang, et al.
Annals of the Rheumatic Diseases|May 10, 2005
Dendritic cells, Fc{gamma} receptors, and Toll-like receptors: potential allies in the battle against rheumatoid arthritisT R D J Radstake, A W T van Lieshout, P L C M van Riel, et al.
Clinical and Experimental Rheumatology|November 7, 2006
Defining remission in psoriatic arthritisA Kavanaugh, J Fransen
Annals of the Rheumatic Diseases|July 3, 2004
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritisC Popa, M G Netea, T Radstake, et al.
Pageof 19